Maternal serum human chorionic gonadotropin as a marker for the delivery of Low-Birth-Weight Infants in women with unexplained elevations in maternal serum α-Fetoprotein

References

• Brock D JG, Darrin L, Jelen P. Maternal serum alpha‐fetoprotein measurements as an early indicator of low birth weight. Lancet 1977; 2: 267–268
   PubMed Web of Science ®Google Scholar
• Wald N, Cuckle H, Stirrat G EN, Bennett M J, Tumbull A C. Maternal serum alpha‐fetoprotein in low birth weight. Lancet 1977; 2: 268–270
   PubMedGoogle Scholar
• Smith M L. Raised maternal serum alpha‐fetoprotein levels and low birth weight babies. Br J Obstet Gynaecol 1980; 87: 1099–1102
   PubMedGoogle Scholar
• Macri J N, Weiss R. Prenatal serum alpha‐fetoprotein screening for neural tube defects. Obstet Gynecol 1982; 59: 633–639
   PubMed Web of Science ®Google Scholar
• Haddow J E, Kloza E M, Smith D E, Knight G J. Data from an alpha‐fetoprotein pilot screening program in Maine. Obstet Gynecol 1983; 62: 556–560
   Google Scholar
• Bucklyn C, Thom H, Campbell A. Maternal serum alpha‐fetoprotein levels in low birth weight singleton pregnancies. J Perinat Med 1984; 12: 127–130
   Google Scholar
• Mariona F G, Hassan N, Syner F, Chic L, Sokol R. Maternal serum alpha‐fetoprotein (msafp) and fetal growth. J Perinat Med 1984; 12: 179–182
   Google Scholar
• Evans J, Stokes I. Outcomes of pregnancies associated with raised serum and normal amniotic fluid alpha‐fetoprotein concentrations. BMJ 1984; 288: 1494
   PubMedGoogle Scholar
• Hamilton M P, Abdalla H I, Whitfield C R. Significance of raised maternal serum alpha‐fetoprotein in singleton pregnancies with normally formed fetuses. Obstet Gynecol 1985; 65: 465–470
   PubMed Web of Science ®Google Scholar
• Burton B, Dillard R. Outcome in infants born to mothers with unexplained elevations of maternal serum alpha‐fetoprotein. Pediatrics 1986; 77: 582–586
   Google Scholar
• Burton B K. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha‐fetoprotein. Obstet Gynecol 1988; 72: 709–713
   PubMed Web of Science ®Google Scholar
• Robinson L, Grau P, Crandle B. Pregnancy outcomes after increasing maternal serum alpha‐fetoprotein levels. Obstet Gynecol 1989; 74: 17–19
   Google Scholar
• Milunsky A, Jick S, Bruell C, et al. Predictive values, relative risks, and overall benefit of high and low maternal serum alpha‐fetoprotein screening in singleton pregnancies: New epidemiologic data. Am J Obstet Gynecol 1989; 161: 291–297
   PubMed Web of Science ®Google Scholar
• Crandall B F, Robinson L, Grau P. Risks associated with an elevated maternal serum alpha‐fetoprotein level. Am J Obstet Gynecol 1991; 165: 581–586
   PubMed Web of Science ®Google Scholar
• Waller D K, Lustig L S, Cunningham G C, Golbus M S, Hook E B. Second trimester maternal serum alpha‐fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991; 325: 610
   Google Scholar
• Thomas R L, Blakemore K J. Evaluation of elevations in maternal serum alpha‐fetoprotein: A review. Obstet Gynecol Surv 1990; 45: 269–283
   PubMedGoogle Scholar
• Chard T, Rice A, Kitau M J, et al. Mid‐trimester levels of alpha‐fetoprotein in the screening of low birth weight. Br J Obstet Gynaecol 1986; 93: 36–38
   PubMedGoogle Scholar
• Bogart M H, Jomes O W, Felder R A, et al. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991; 165: 663–667
   PubMedGoogle Scholar
• Gonen R, Perez R, David M, et al. The association between unexplained second‐trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992; 80: 83–86
   PubMed Web of Science ®Google Scholar
• MacDonald M L, Wagner R M, Slotnick R N. Sensitivity and specificity of screening for down's syndrome with alpha‐fetoprotein, MShCG, unconjugated estriol, and maternal age. Obstet Gynecol 1991; 77: 63–68
   PubMed Web of Science ®Google Scholar
• Miller C H, O'Brien T J, Chatelain S, Butler B B, Quirk J G. Maternal Serum alpha‐fetoprotein and human chorionic gonadotropin screening for chromosomal trisomies. Prenat Diagn 1991; 11: 153–158
   Google Scholar
• Wald N J, Cuckle H S, Densem J W, et al. Maternal serum screening for down's syndrome in early pregnancy. BMJ 1988; 297: 883–887
   PubMed Web of Science ®Google Scholar
• Usher R, McClean F J. Intrauterine growth of live‐born caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1967; 71: 159
   Google Scholar
• Richardson D K, Schwartz J S, Weinbaum P J, Gabbe S G. Diagnostic tests in obstetrics: A method for improved evaluation. Am J Obstet Gynecol 1985; 152: 613–618
   PubMed Web of Science ®Google Scholar
• Tanaka M, Natoni M, Kohno H, et al. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993; 81: 341–343
   PubMed Web of Science ®Google Scholar